Psychosis — Cognitive Remediation and Social Recovery in Early Psychosis
Citation(s)
Addington J, Saeedi H, Addington D Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophr Res. 2006 Jul;85(1-3):142-50. Epub 2006 May 5.
Bora E, Yucel M, Pantelis C Theory of mind impairment in schizophrenia: meta-analysis. Schizophr Res. 2009 Apr;109(1-3):1-9. doi: 10.1016/j.schres.2008.12.020. Epub 2009 Feb 4.
CREW (2012) De?nition of Cognitive Remediation. Cognitive Remediation Expert Working Group: Florence, Italy.
Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. 2011 Jan;35(3):573-88. doi: 10.1016/j.neubiorev.2010.07.001. Epub 2010 Jul 8. Review.
Fiszdon JM, Reddy LF Review of social cognitive treatments for psychosis. Clin Psychol Rev. 2012 Dec;32(8):724-40. doi: 10.1016/j.cpr.2012.09.003. Epub 2012 Sep 21. Review.
Fowler D, Hodgekins J, French P Social Recovery Therapy in improving activity and social outcomes in early psychosis: Current evidence and longer term outcomes. Schizophr Res. 2019 Jan;203:99-104. doi: 10.1016/j.schres.2017.10.006. Epub 2017 Oct 22.
Green MF, Horan WP, Lee J Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019 Jun;18(2):146-161. doi: 10.1002/wps.20624.
Green, M F., & Horan, W. P. (2010). Social Cognition in Schizophrenia. Current Directions in Psychological Science, 19(4), 243-248. https://doi.org/10.1177/0963721410377600
Horan WP, Kern RS, Shokat-Fadai K, Sergi MJ, Wynn JK, Green MF Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophr Res. 2009 Jan;107(1):47-54. doi: 10.1016/j.schres.2008.09.006. Epub 2008 Oct 18.
Kurtz MM, Richardson CL Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research. Schizophr Bull. 2012 Sep;38(5):1092-104. doi: 10.1093/schbul/sbr036. Epub 2011 Apr 27.
Pinkham AE, Penn DL, Green MF, Buck B, Healey K, Harvey PD The social cognition psychometric evaluation study: results of the expert survey and RAND panel. Schizophr Bull. 2014 Jul;40(4):813-23. doi: 10.1093/schbul/sbt081. Epub 2013 May 31.
Reeder C, Huddy V, Cella M, Taylor R, Greenwood K, Landau S, Wykes T A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial. Psychol Med. 2017 Sep 4:1-11. doi: 10.1017/S0033291717001234. [Epub ahead of print]
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
